Objective: The aim of this study was to evaluate the levels of matrix metalloproteinase-12 (MMP-12) and tissue inhibitors of metalloproteinases (TIMP)-1, TIMP-2, TIMP3, and TIMP-4 in patients with symptomatic and asymptomatic critical carotid artery stenosis (CAS). Methods: We enrolled 10 patients affected by symptomatic CAS within 12 hours from onset of stroke (S group) and 30 patients with asymptomatic CAS (CAS group); 31 patients matched for age, sex, and traditional cardiovascular risk factors were used as controls (RF group). Serum levels of MMP-12, TIMP-1, TIMP-2, TIMP-3, and TIMP-4 were assessed by Luminex. Results: MMP-12 levels were significantly higher both in the S and CAS groups than in the RF group (P <.001). We found a significant decrease of all TIMPs in the CAS group compared with the RF group, whereas a significant increase was observed in the S group compared with the CAS group. A significant increase of TIMP-3 and TIMP-4 levels was observed in the S group compared with all other groups. Conclusion: MMP-12 is related to critical CAS both symptomatic and asymptomatic, being mainly released in the late stage of plaque development. Moreover, we suggest that a specific pattern of matrix degrading enzyme inhibitors arises during the early phases of stroke.

MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis / DEL PORTO, Flavia; Cifani, Noemi; Proietta, Maria; Toni, Danilo; Taurino, Maurizio. - In: JOURNAL OF STROKE AND CEREBROVASCULAR DISEASES. - ISSN 1052-3057. - STAMPA. - 26:(2017), pp. 334-338. [10.1016/j.jstrokecerebrovasdis.2016.09.025]

MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis

DEL PORTO, Flavia;CIFANI, NOEMI;TONI, Danilo;TAURINO, Maurizio
2017

Abstract

Objective: The aim of this study was to evaluate the levels of matrix metalloproteinase-12 (MMP-12) and tissue inhibitors of metalloproteinases (TIMP)-1, TIMP-2, TIMP3, and TIMP-4 in patients with symptomatic and asymptomatic critical carotid artery stenosis (CAS). Methods: We enrolled 10 patients affected by symptomatic CAS within 12 hours from onset of stroke (S group) and 30 patients with asymptomatic CAS (CAS group); 31 patients matched for age, sex, and traditional cardiovascular risk factors were used as controls (RF group). Serum levels of MMP-12, TIMP-1, TIMP-2, TIMP-3, and TIMP-4 were assessed by Luminex. Results: MMP-12 levels were significantly higher both in the S and CAS groups than in the RF group (P <.001). We found a significant decrease of all TIMPs in the CAS group compared with the RF group, whereas a significant increase was observed in the S group compared with the CAS group. A significant increase of TIMP-3 and TIMP-4 levels was observed in the S group compared with all other groups. Conclusion: MMP-12 is related to critical CAS both symptomatic and asymptomatic, being mainly released in the late stage of plaque development. Moreover, we suggest that a specific pattern of matrix degrading enzyme inhibitors arises during the early phases of stroke.
2017
Critical carotid artery stenosis; MMP-12; TIMPs; stroke
01 Pubblicazione su rivista::01a Articolo in rivista
MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis / DEL PORTO, Flavia; Cifani, Noemi; Proietta, Maria; Toni, Danilo; Taurino, Maurizio. - In: JOURNAL OF STROKE AND CEREBROVASCULAR DISEASES. - ISSN 1052-3057. - STAMPA. - 26:(2017), pp. 334-338. [10.1016/j.jstrokecerebrovasdis.2016.09.025]
File allegati a questo prodotto
File Dimensione Formato  
MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis.pdf

solo gestori archivio

Note: Del Porto_MMP-12 and TIMP Behavior_2017
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 111.16 kB
Formato Adobe PDF
111.16 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/908273
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 4
social impact